Bellberry’s CEO, Kylie Sproston, said the 2024 data show that Australia is uniquely positioned to attract global investment in clinical trials due to the high quality of its healthcare institutions and researchers.
Report highlights international confidence in Australian clinical trials
May 19, 2025 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Mesoblast updates investors on the succesful US launch of cell medicine
July 20, 2025 - - Australian Biotech -
Australian researcher awarded Gilead Sciences global grant to explore novel approach in breast cancer
July 18, 2025 - - Latest News -
The 'Dispatched' Week in Review Podcast - 17 July
July 17, 2025 - - Podcast -
Another day, another confusing response to the threat of US tariffs
July 17, 2025 - - Latest News -
NDIS keeps growing but signs emerge that reforms are starting to work
July 17, 2025 - - Latest News -
USTR launches new investigation, with minimal ambition on pharmaceuticals
July 17, 2025 - - Latest News -
New Zealand starting to benefit after lifting advertising prohibition
July 17, 2025 - - Latest News